These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4939817)

  • 1. Prolongation of mouse skin allograft survival by treatment with cytosine arabinoside in combination with F 1 hybrid lymphocytes.
    Amaku EO; May AG; Hall TC; Linke CA
    Transplantation; 1971 Oct; 12(4):249-52. PubMed ID: 4939817
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of skin allograft survival in lymphocyte-depleted mice.
    Deaton JG; Bach FH
    Transplantation; 1970 Jun; 9(6):597-9. PubMed ID: 4911418
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic studies and effect on skin allograft survival of DBA-2 DAG, Ly, and M-locus antigens.
    Sachs JA; Huber B; Peña-Martinez J; Festenstein H
    Transplant Proc; 1973 Dec; 5(4):1385-7. PubMed ID: 4590621
    [No Abstract]   [Full Text] [Related]  

  • 4. Contributions of the rat to the immunobiology of tissue transplantation.
    Silvers WK; Billingham RE
    Transplant Proc; 1970 Mar; 2(1):152-61. PubMed ID: 4398945
    [No Abstract]   [Full Text] [Related]  

  • 5. Is antibody essential for enhancement of skin allograft survival following preinjection of donor lymphocyte antigens?
    Lee CK; Reif AE; Deterling RA
    Transplantation; 1972 Mar; 13(3):339-43. PubMed ID: 4553736
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific inhibition of organ allograft rejection by donor blood.
    Marquet RL; Heystek GA; Tinbergen WJ
    Transplant Proc; 1971 Mar; 3(1):708-10. PubMed ID: 4937963
    [No Abstract]   [Full Text] [Related]  

  • 7. Retrospective leukocyte typing of unrelated human donor-recipient pairs in relation to skin allograft survival times. A study of 17 well defined specificities.
    Walford RL; Colombani J; Dausset J
    Transplantation; 1969 Mar; 7(3):188-93. PubMed ID: 4888499
    [No Abstract]   [Full Text] [Related]  

  • 8. The immunosuppressive effects of adamantoyl cytarabine. II. Effects on skin allograft rejection by rats and mice.
    Gray GD; Mickelson MM
    Transplantation; 1970 Feb; 9(2):176-8. PubMed ID: 4905927
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolonged survival time of skin allotransplants after cytosine arabinoside (CA)].
    Weitzel H; Rother K
    Verh Dtsch Ges Pathol; 1970; 54():169-75. PubMed ID: 4104525
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged survival of rabbit skin and kidney allografts following donor treatment with cytosine arabinoside.
    Beyer MM; Friedman EA
    Transplantation; 1975 Jan; 19(1):60-3. PubMed ID: 1091032
    [No Abstract]   [Full Text] [Related]  

  • 11. Humoral antibody in allograft reactions.
    Winn HJ
    Transplant Proc; 1970 Mar; 2(1):83-91. PubMed ID: 4107296
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolongation of skin graft survival by donor treatment (donor enhancement).
    Barkin M; Hambly EJ; Dimitriu D
    Transplantation; 1972 Jan; 13(1):18-20. PubMed ID: 4550342
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms in the acceptance of organ grafts.
    Calne RY
    Br Med Bull; 1976 May; 32(2):107-12. PubMed ID: 782630
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolongation of allograft survival in mice by inducers of interferon.
    Mobraaten LE; De Maeyer E; De Maeyer-Guignard J
    Transplantation; 1973 Nov; 16(5):415-20. PubMed ID: 4356708
    [No Abstract]   [Full Text] [Related]  

  • 15. TRANSPLANTATION TOLERANCE INDUCED IN ADULT MICE BY PROTEIN OVERLOADING OF DONORS.
    LIACOPOULOS P; GOODE JH
    Science; 1964 Dec; 146(3649):1305-7. PubMed ID: 14207456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKIN HOMOGRAFT SURVIVAL IN THE RABBIT AFTER THE ADMINISTRATION OF WHOLE BLOOD.
    SNYDER GB; EBERT PA; EDGERTON MT
    Bull Johns Hopkins Hosp; 1965 Feb; 116():95-9. PubMed ID: 14261149
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serology of organ transplantation].
    Mayr WR
    Wien Klin Wochenschr; 1970 Jan; 82(2):21-8 passim. PubMed ID: 4934917
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term skin allograft survical elicited by a finite treatment with antilymphocyte serum combined with cytarabine.
    Perper RJ; Monovich RE; Bowersox BE
    J Immunol; 1970 May; 104(5):1063-71. PubMed ID: 4910473
    [No Abstract]   [Full Text] [Related]  

  • 19. The new serology of histocompatibility testing and its significance in human renal transplantation.
    Braun WE
    Urol Clin North Am; 1976 Oct; 3(3):503-25. PubMed ID: 136083
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolongation of allograft survival in mice by transplantation antigens incubated with normal serum. 1. Identification of the active serum fraction].
    Elie R; Liabeuf A; Lamoureux G
    Ann Immunol (Paris); 1973 Nov; 124(4):539-54. PubMed ID: 4134957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.